Overview: Strategies will be presented in defining what is an acceptable bio burden and a bio burden that demonstrates material release issues. Risk analysis is a key component of these strategies.
Areas Covered in the Session:
- Defining contamination in non-sterile pharmaceuticals
- Means of ingress of contamination
- Review of cleaning and sanitization
- Adapting Investigations for the recognition of historical and atypical trends